1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Romiplostim in a case series of chemotherapy-induced thrombocytopenia
    Meeting Abstract

    Parameswaran, R.; Soff, G. A.
    Blood (2011)

    Fulltext@MSK | Save
  • Genomic safe harbors in human iPS cells
    Meeting Abstract

    Papapetrou, E. P.; Sadelain, M.; Bushman, F.
    Blood (2011)

    Fulltext@MSK | Save
  • FTY720 restores PP2A tumor suppressor activity in polycythemia vera CD34(+) progenitors through inhibition of jak2 V617F-and PI-3K gamma-dependent SET serine phosphorylation and enhancement of NOS-dependent PP2A tyrosine nitration
    Meeting Abstract

    Oaks, J. J.; Mukhopadhyay, A.; Santhanam, R.; Saddoughi, S. A.; Neviani, P.; Harb, J. G.; Ogretmen, B.; Bittman, R.; Levine, R. L.; Quintas-Cardama, A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Using a Weibull parametric model for failure-time data to assess progression-free survival as a surrogate endpoint for overall survival in a trial of patients with metastatic renal cell carcinoma
    Meeting Abstract

    Negrier, S.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Sandin, R.; Michaelson, M. D.; Figlin, R. A.; Motzer, R. J.
    Value in Health (2011)

    Fulltext@MSK | Save
  • Evaluating clonal dominance in a murine knock-in model of jak2V617F MPN
    Meeting Abstract

    Mullally, A.; Poveromo, L.; Brumme, K.; Al-Shahrour, F.; Lane, S. W.; Shih, A. H.; Aifantis, I.; Levine, R. L.; Ebert, B. L.
    Blood (2011)

    Fulltext@MSK | Save
  • MRI for breast cancer screening & staging
    Meeting Abstract

    Morrow, M.
    Menopause (2011)

    Fulltext@MSK | Save
  • In vivo RNA interference screening identifies a leukemia-specific dependence on integrin beta 3 signaling
    Meeting Abstract

    Miller, P.; Al-Shahrour, F.; Hartwell, K. A.; Chu, L. P.; Marcus, J.; Puram, R. V.; Puissant, A.; Callahan, K.; Ashton, J. M.; McConkey, M. E.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Epigenetic effects of IDH1/IDH2 mutations
    Meeting Abstract

    Melnick, A. M.; Levine, R. L.; Figueroa, M. E.; Thompson, C. B.; Abdel-Wahab, O.
    Blood (2011)

    Fulltext@MSK | Save
  • A phase II study of ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory aggressive B-cell lymphoma prior to autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Ruxolitinib, a janus kinase (JAK)-1 and-2 inhibitor modulates microrna (miR) levels in patients with myelofibrosis (MF): miR levels might predict MF treatment outcome
    Meeting Abstract

    Manshouri, T.; Estrov, Z.; Knez, L.; Zhang, Y.; Levine, R. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save